Differentiating recurrent tumor from radiation necrosis: Time for re- evaluation of positron emission tomography?

American Journal of Neuroradiology

Volumn 19, Issue 3, 1998, Pages 407-413

  Ricci, Peter E ^a   Karis, John P ^a   Heiserman, Joseph E ^a   Fram, Evan K ^a   Bice, Alden N ^a   Drayer, Burton P ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION NECROSIS; RECURRENT CANCER; RETROSPECTIVE STUDY;

DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; NECROSIS; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032231697     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986;158:149-155
2. Mikhael MA. Radiation necrosis of the brain: correlation between, computed tomography, pathology and dose distribution. J Comput Assist Tomogr 1978;2:71-80
3. Kingsley DPE, Kendall BE. CT of the adverse effects of therapeutic radiation of the central nervous system. AJNR Am J Neuroradiol 1981;2:453-460
4. van Dellen JR, Danziger A. Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour. S Afr Med J 1978;53:171-172
5. Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol 1991;12:45-62
6. Patronas NJ, Di Chiro G, Brooks RA, et al. Work in progress: 18F fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982;144:885-889
7. Doyle WK, Budinger TF, Valk PE, Levin VA, Gutin PH. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 1987;11:563-570
8. Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol 1988;150: 189-197
9. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK. PET of malignant tumors after interstitial brachytherapy: demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 1988;69:830-838
10. Glantz MJ, Hoffman JM, Coleman RE, et al. Identification of early recurrence of primary central nervous system tumors by 18F-fluorodeoxyglucose positron emission tomography. Ann Neurol 1991;29:347-355
11. Ogawa T, Kanno I, Shishido F, et al. Clinical value of PET with [18F]fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991;32:197-202
12. Kim EE, Chung S-K, Haynie TP, et al. Differentiation of residual or recurrent tumors from post-treatment changes in F-18 FDG PET. Radiographics 1992;12:269-279
13. 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994;163:1459-1465
14. Olivero WC, Dulebohn SC, Lister JR. The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry 1995;58:250-252
15. Rota Kops E, Herzog H, Schmid A, Holte S, Feinendengen LE. Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr 1990;14:437-445
16. Warburg O. On the origin of cancer cells. Science 1956;123:309-314
17. Gerber GB, Altman KI. Radiation Biochemistry of Tumors. In: Altman KI, Gerber GB, Okada S, eds Radiation Biochemistry. Vol 2. New York, NY: Academic Press; 1970:235-247
18. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388
19. Gober JR. Noninvasive tissue characterization of brain tumors and radiation therapy using MR spectroscopy. Neuroimaging Clin N Am 1993;3:779-802
20. Davis WK, Boyko OB, Hoffman JM, et al. [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol 1993;14:515-523
21. Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas by 18F fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329
22. Boyko OB. Neuroimaging of radiation injury to the central nervous system. Neuroimaging Clin N Am 1993;3:803-816
23. Kim CK, Alavi JB, Alavi A, Reivich M. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 1991;10:85-91
24. Di Chiro G and Fulham MJ. Virchow's shackles: can PET-FDG challenge tumor histology? AJNR Am J Neuroradiol 1993;14:524-527